Most accredited investors get burned not by bad assets but by bad questions. Here are the five you must ask before any capital commitment.
Most accredited investors don't lose capital because they picked the wrong asset class. They lose it because they committed before asking the right questions — and sponsors who can't answer them cleanly rarely volunteer that information upfront.
The five questions below are not a checklist of pleasantries. They are a clinical filter. Apply them before any capital commitment, regardless of how well-packaged the opportunity looks.
The projected IRR is the number most sponsors lead with — and the number least likely to reflect reality without pressure-testing. An IRR figure in isolation tells you almost nothing. What matters is the set of assumptions underneath it.
Before you read the return projection as a signal of quality, ask the sponsor to walk you through the three inputs that move the IRR the most: rent growth rate, exit cap rate, and hold period. Then ask what happens to the IRR if each of those assumptions is wrong by 10 to 15 percent in the wrong direction.
A sponsor who has done this analysis will answer without hesitation. A sponsor who hasn't — or who deflects toward the base case — is telling you something important.
Key follow-up questions:
Solid operators model a downside case as a matter of discipline. If the sponsor you're speaking with has not done this, that is the diligence finding.
Every deal has a projected hold period. Not every deal has a clearly defined exit strategy — and the difference between those two things can cost you years of trapped capital.
Ask the sponsor to describe the exit in specific terms: Are they selling to a strategic buyer, recapitalizing with new debt, or targeting a 1031 exchange buyer pool? And more importantly — what triggers the decision to exit? Is it a target return threshold, a market condition, or simply the end of a fund term?
The follow-up question matters more: who has final authority over the exit decision? In most syndications structured under a 506(c) offering, the GP holds broad discretion over timing. That is normal — but you should understand it before you commit, not after.
Key follow-up questions:
Liquidity in private real estate is not guaranteed. The exit strategy is the only mechanism through which your capital comes back. Treat it accordingly.
A track record slide in a pitch deck is marketing. A verifiable track record is a different thing entirely.
Ask for audited financials or third-party verified performance data on prior deals — not projected returns, not testimonials, not a list of assets they have "been involved with." You want actual exit data: what was the projected IRR on deals that have closed, and what was the realized IRR? How did those numbers compare?
The SEC's guidance on assessing accredited investors under Regulation D outlines the regulatory framework for these offerings, but it places the burden of sponsor diligence squarely on the investor. The platform that introduced you to the deal does not bear that responsibility — you do.
For sponsors who are earlier in their operating history, the right question is not "how many deals have you closed" but rather "can I speak with a current LP about their experience with your reporting and communication?"
Key follow-up questions:
Selly's accredited investor deal matching program requires every sponsor to pass a 360-degree verification before a deal reaches the investor pipeline — which is a floor, not a ceiling, for your own diligence.
Fees in private real estate syndications are not standardized, and the variance between structures can materially affect your net returns — even on deals with identical gross projections.
The common fee categories to ask about: acquisition fee (typically 1–3% of purchase price), asset management fee (typically 1–2% of gross revenue or asset value annually), disposition fee (typically 1–2% of sale price), and promote structure (the GP's share of profits above the preferred return threshold).
None of these fees are inherently unreasonable. What is unreasonable is a sponsor who cannot explain them clearly, discloses them only in the PPM footnotes, or structures them in a way that creates misaligned incentives — for example, an acquisition fee that rewards deal volume over deal quality.
Key follow-up questions:
A sponsor who presents a clean, one-page fee summary without being asked is demonstrating operator alignment. That behavior matters.
Every deal is a bet on a market — a submarket, an asset class, a demand driver, a demographic trend. The market thesis is the sponsor's argument for why this asset, in this location, at this price, makes sense right now.
The question is not whether the thesis sounds compelling. It is whether the thesis is falsifiable — meaning, can the sponsor articulate what would have to be true for the thesis to be wrong?
A strong market thesis is specific: "We are buying in a submarket where multifamily supply has been constrained by zoning since 2019, employment growth is outpacing regional averages by 2.3 points, and the current cap rate represents a 75-basis-point discount to comparable trades in adjacent submarkets." A weak thesis is general: "Houston is a great long-term market with strong fundamentals."
For context on how Houston's real estate market compares to broader Sun Belt dynamics in 2025, the Houston real estate market analysis on this site is a useful reference point.
The SEC's accredited investor framework gives qualified investors broader access to private placements precisely because they are assumed to have the financial sophistication to evaluate these arguments independently. Use that capacity.
Key follow-up questions:
Accredited status gives you access. It does not give you an edge. That edge comes from asking better questions than the next investor in the pipeline — before the documents are signed, before the wire goes out, and before the hold period begins.
The five questions above are not exhaustive. But a sponsor who can answer all five clearly, specifically, and without hesitation has demonstrated something that no pitch deck can: that they understand their own deal well enough to defend it under scrutiny.
Selly reviews every deal in the investor pipeline against the same framework before it reaches a single inbox. If you want curated access to vetted operators and deals structured with institutional discipline, the process starts with a conversation.
